These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of the COVID-19 pandemic on therapeutic choices in thrombosis-hemostasis. Hermans C; Lambert C J Thromb Haemost; 2020 Jul; 18(7):1794-1795. PubMed ID: 32294321 [No Abstract] [Full Text] [Related]
4. Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic. Marchandot B; Trimaille A; Curtiaud A; Matsushita K; Jesel L; Morel O J Thromb Thrombolysis; 2020 Nov; 50(4):799-808. PubMed ID: 32696172 [TBL] [Abstract][Full Text] [Related]
5. Heparin resistance in COVID-19 patients in the intensive care unit. White D; MacDonald S; Bull T; Hayman M; de Monteverde-Robb R; Sapsford D; Lavinio A; Varley J; Johnston A; Besser M; Thomas W J Thromb Thrombolysis; 2020 Aug; 50(2):287-291. PubMed ID: 32445064 [TBL] [Abstract][Full Text] [Related]
6. COVID-19 and thrombosis: Beyond a casual association. López Castro J Med Clin (Barc); 2020 Jul; 155(1):44. PubMed ID: 32446683 [No Abstract] [Full Text] [Related]
7. Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19. Busch MH; Timmermans SAMEG; Nagy M; Visser M; Huckriede J; Aendekerk JP; de Vries F; Potjewijd J; Jallah B; Ysermans R; Oude Lashof AML; Breedveld PH; van de Poll MCG; van de Horst ICC; van Bussel BCT; Theunissen ROMFIH; Spronk HMH; Damoiseaux JGMC; Ten Cate H; Nicolaes GAF; Reutelingsperger CP; van Paassen P Circulation; 2020 Nov; 142(18):1787-1790. PubMed ID: 32946302 [No Abstract] [Full Text] [Related]
8. Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2. Pamukçu B Anatol J Cardiol; 2020 Oct; 24(4):224-234. PubMed ID: 33001051 [TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. Hasan SS; Radford S; Kow CS; Zaidi STR J Thromb Thrombolysis; 2020 Nov; 50(4):814-821. PubMed ID: 32748122 [TBL] [Abstract][Full Text] [Related]
13. Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19. Bautista-Vargas M; Bonilla-Abadía F; Cañas CA J Thromb Thrombolysis; 2020 Oct; 50(3):479-483. PubMed ID: 32519164 [TBL] [Abstract][Full Text] [Related]
14. Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase. DiNicolantonio JJ; McCarty M Open Heart; 2020 Jun; 7(1):. PubMed ID: 32532805 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns. Wanderer JP; Nathan N Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849 [No Abstract] [Full Text] [Related]
16. In vivo demonstration of microvascular thrombosis in severe COVID-19. do Espírito Santo DA; Lemos ACB; Miranda CH J Thromb Thrombolysis; 2020 Nov; 50(4):790-794. PubMed ID: 32789730 [TBL] [Abstract][Full Text] [Related]
17. Spontaneous Major Hemorrhage in COVID-19 Patients: Another Brick in the Wall of SARS-CoV-2-Associated Coagulation Disorders? Palumbo D; Guazzarotti G; De Cobelli F J Vasc Interv Radiol; 2020 Sep; 31(9):1494-1496. PubMed ID: 32768277 [No Abstract] [Full Text] [Related]
18. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. Ranucci M; Ballotta A; Di Dedda U; Baryshnikova E; Dei Poli M; Resta M; Falco M; Albano G; Menicanti L J Thromb Haemost; 2020 Jul; 18(7):1747-1751. PubMed ID: 32302448 [TBL] [Abstract][Full Text] [Related]